Divi's Laboratories (NSE:DIVISLAB) 5-Year Share Buyback Ratio : 0.00% (As of Mar. 2025)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories 5-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

5-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past five years. It is calculated as the annualized percentage change in shares outstanding from five years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Divi's Laboratories's current 5-Year Share Buyback Ratio was 0.00%.

NSE:DIVISLAB's 5-Year Share Buyback Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -2.9
* Ranked among companies with meaningful 5-Year Share Buyback Ratio only.

Competitive Comparison of Divi's Laboratories's 5-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Divi's Laboratories's 5-Year Share Buyback Ratio, along with its competitors' market caps and 5-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Divi's Laboratories's 5-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Divi's Laboratories's 5-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Divi's Laboratories's 5-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Divi's Laboratories 5-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from five years ago to the current year. The annualized percentage change is calculated with least-square regression based on the latest six years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Divi's Laboratories (NSE:DIVISLAB) 5-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Divi's Laboratories 5-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's 5-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (NSE:DIVISLAB) » Definitions » 5-Year Share Buyback Ratio

Traded in Other Exchanges

532488:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines